
Keywords: ACE; angiotensin converting enzyme; ARBs; angiotensin II receptor blockers; AT1; angiotensin II receptor type-1; AT2; angiotensin II receptor type-2; CCBs; calcium channel-blockers; CKD; chronic kidney disease; CysA; cyclosporine A; ERAs; endothelin recep